Can't complain really - very very detailed investor update. Must have taken Karen Negus hours. Hoping fy 2018 leads to Tesserent being operationally cash flow positive.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025